Viral Vector Purification CAGR of 14.2% during the forecast period of 2025 to 2032.
Introduction
Viral Vector Purification is a crucial process in biotechnology and biopharmaceutical manufacturing that ensures the removal of impurities and contaminants from viral vectors used in gene therapy, vaccine development, and cell therapy. Viral vectors—such as adenovirus, adeno-associated virus (AAV), and lentivirus—are engineered viruses that deliver therapeutic genes to target cells.
As viral vector–based therapies gain traction in treating genetic and chronic diseases, the demand for high-quality, scalable purification methods has grown significantly. Effective purification ensures safety, efficacy, and regulatory compliance of advanced therapeutics.
What Is Viral Vector Purification?
Viral vector purification is the downstream processing step in viral vector manufacturing, where viral particles are separated from cell debris, host cell proteins, nucleic acids, and other impurities. The goal is to obtain a high-purity, high-yield viral vector preparation suitable for clinical or commercial use.
This process combines filtration, centrifugation, and chromatography techniques to ensure the final product meets strict quality standards.
